{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:54:34Z","timestamp":1787504074349,"version":"build-2736575974"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P51OD11132"],"award-info":[{"award-number":["P51OD11132"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM035463"],"award-info":[{"award-number":["R01 GM035463"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F31 CA196181"],"award-info":[{"award-number":["F31 CA196181"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics &amp; Chromatin"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Huntington\u2019s Disease (HD) is a fatal neurodegenerative disorder caused by a CAG repeat expansion, resulting in a mutant huntingtin protein. While it is now clear that astrocytes are affected by HD and significantly contribute to neuronal dysfunction and pathogenesis, the alterations in the transcriptional and epigenetic profiles in HD astrocytes have yet to be characterized. Here, we examine global transcription and chromatin accessibility dynamics during in vitro astrocyte differentiation in a transgenic non-human primate model of HD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found global changes in accessibility and transcription across different stages of HD pluripotent stem cell differentiation, with distinct trends first observed in neural progenitor cells (NPCs), once cells have committed to a neural lineage. Transcription of p53 signaling and cell cycle pathway genes was highly impacted during differentiation, with depletion in HD NPCs and upregulation in HD astrocytes. E2F target genes also displayed this inverse expression pattern, and strong associations between E2F target gene expression and accessibility at nearby putative enhancers were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results suggest that chromatin accessibility and transcription are altered throughout in vitro HD astrocyte differentiation and provide evidence that E2F dysregulation contributes to aberrant cell-cycle re-entry and apoptosis throughout the progression from NPCs to astrocytes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13072-019-0313-6","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T01:03:10Z","timestamp":1573606990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington\u2019s Disease Monkey pluripotent stem cells"],"prefix":"10.1186","volume":"12","author":[{"given":"Alexandra V.","family":"Goodnight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Kremsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujittra","family":"Khampang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Bosinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5140-4337","authenticated-orcid":false,"given":"Victor G.","family":"Corces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W. S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"key":"313_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev. 2010;90:905\u201381.","journal-title":"Physiol Rev"},{"key":"313_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41536-019-0066-7","volume":"4","author":"IK Cho","year":"2019","unstructured":"Cho IK, Hunter CE, Ye S, Pongos AL, Chan AWS. Combination of stem cell and gene therapy ameliorates symptoms in Huntington\u2019s disease mice. NPJ Regen Med. 2019;4:7.","journal-title":"NPJ Regen Med"},{"key":"313_CR3","doi-asserted-by":"publisher","first-page":"e0214156","DOI":"10.1371\/journal.pone.0214156","volume":"14","author":"IK Cho","year":"2019","unstructured":"Cho IK, Yang B, Forest C, Qian L, Chan AWS. Amelioration of Huntington\u2019s disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington\u2019s disease monkeys. PLoS ONE. 2019;14:e0214156.","journal-title":"PLoS ONE"},{"key":"313_CR4","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1021\/bi101208k","volume":"49","author":"KT Gagnon","year":"2010","unstructured":"Gagnon KT, Pendergraff HM, Deleavey GF, Swayze EE, Potier P, Randolph J, Roesch EB, Chattopadhyaya J, Damha MJ, Bennett CF, et al. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry. 2010;49:10166\u201378.","journal-title":"Biochemistry"},{"key":"313_CR5","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1016\/j.bmcl.2009.09.004","volume":"19","author":"J Hu","year":"2009","unstructured":"Hu J, Dodd DW, Hudson RH, Corey DR. Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy)phenyl]pyrrolocytosine. Bioorg Med Chem Lett. 2009;19:6181\u20134.","journal-title":"Bioorg Med Chem Lett"},{"key":"313_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.2993","volume":"226","author":"JK Watts","year":"2012","unstructured":"Watts JK, Corey DR. Silencing disease genes in the laboratory and the clinic. J Pathol. 2012;226:365\u201379.","journal-title":"J Pathol"},{"key":"313_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","volume":"150","author":"D Yu","year":"2012","unstructured":"Yu D, Pendergraff H, Liu J, Kordasiewicz HB, Cleveland DW, Swayze EE, Lima WF, Crooke ST, Prakash TP, Corey DR. Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell. 2012;150:895\u2013908.","journal-title":"Cell"},{"key":"313_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90:537\u201348.","journal-title":"Cell"},{"key":"313_CR9","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277:1990\u20133.","journal-title":"Science"},{"key":"313_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00019052-199408000-00009","volume":"7","author":"YP Goldberg","year":"1994","unstructured":"Goldberg YP, Telenius H, Hayden MR. The molecular genetics of Huntington\u2019s disease. Curr Opin Neurol. 1994;7:325\u201332.","journal-title":"Curr Opin Neurol"},{"key":"313_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jmg.30.12.982","volume":"30","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, Myers RH, Gray J, Conneally PM, Young A, Penney J, et al. Gametic but not somatic instability of CAG repeat length in Huntington\u2019s disease. J Med Genet. 1993;30:982\u20136.","journal-title":"J Med Genet"},{"key":"313_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1006\/exnr.1998.7005","volume":"156","author":"KA Sieradzan","year":"1999","unstructured":"Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N, Mann DM. Huntington\u2019s disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol. 1999;156:92\u20139.","journal-title":"Exp Neurol"},{"key":"313_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet. 1993;4:393\u20137.","journal-title":"Nat Genet"},{"key":"313_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci. 2005;6:919\u201330.","journal-title":"Nat Rev Neurosci"},{"key":"313_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","volume":"90","author":"E Scherzinger","year":"1997","unstructured":"Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 1997;90:549\u201358.","journal-title":"Cell"},{"issue":"2","key":"313_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"The\u00a0HD\u00a0iPSC\u00a0Consortium","year":"2012","unstructured":"Consortium HDi: Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 2012, 11:264-278.","journal-title":"Cell Stem Cell"},{"key":"313_CR17","doi-asserted-by":"publisher","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf A, Hoss AG, Lagomarsino V, Latourelle JC, Hadzi TC, Bregu J, MacDonald ME, Gusella JF, Chen JF, Akbarian S, et al. RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS ONE. 2015;10:e0143563.","journal-title":"PLoS ONE"},{"key":"313_CR18","doi-asserted-by":"publisher","first-page":"e0148680","DOI":"10.1371\/journal.pone.0148680","volume":"11","author":"C Lopes","year":"2016","unstructured":"Lopes C, Aubert S, Bourgois-Rocha F, Barnat M, Rego AC, Deglon N, Perrier AL, Humbert S. Dominant-negative effects of adult-onset Huntingtin mutations alter the division of human embryonic stem cells-derived neural cells. PLoS ONE. 2016;11:e0148680.","journal-title":"PLoS ONE"},{"key":"313_CR19","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1073\/pnas.1603871113","volume":"113","author":"AE Molero","year":"2016","unstructured":"Molero AE, Arteaga-Bracho EE, Chen CH, Gulinello M, Winchester ML, Pichamoorthy N, Gokhan S, Khodakhah K, Mehler MF. Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington\u2019s disease. Proc Natl Acad Sci USA. 2016;113:5736\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR20","doi-asserted-by":"publisher","first-page":"21900","DOI":"10.1073\/pnas.0912171106","volume":"106","author":"AE Molero","year":"2009","unstructured":"Molero AE, Gokhan S, Gonzalez S, Feig JL, Alexandre LC, Mehler MF. Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington\u2019s disease. Proc Natl Acad Sci USA. 2009;106:21900\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","volume":"45","author":"T Seredenina","year":"2012","unstructured":"Seredenina T, Luthi-Carter R. What have we learned from gene expression profiles in Huntington\u2019s disease? Neurobiol Dis. 2012;45:83\u201398.","journal-title":"Neurobiol Dis"},{"key":"313_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dev.156844","volume":"145","author":"A Ruzo","year":"2018","unstructured":"Ruzo A, Croft GF, Metzger JJ, Galgoczi S, Gerber LJ, Pellegrini C, Wang H, Fenner M, Tse S, Marks A, et al. Chromosomal instability during neurogenesis in Huntington\u2019s disease. Development. 2018;145:1.","journal-title":"Development"},{"key":"313_CR23","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1007\/s12035-017-0477-7","volume":"55","author":"K Wiatr","year":"2018","unstructured":"Wiatr K, Szlachcic WJ, Trzeciak M, Figlerowicz M, Figiel M. Huntington disease as a neurodevelopmental disorder and early signs of the disease in stem cells. Mol Neurobiol. 2018;55:3351\u201371.","journal-title":"Mol Neurobiol"},{"key":"313_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddq018","volume":"19","author":"K Becanovic","year":"2010","unstructured":"Becanovic K, Pouladi MA, Lim RS, Kuhn A, Pavlidis P, Luthi-Carter R, Hayden MR, Leavitt BR. Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum Mol Genet. 2010;19:1438\u201352.","journal-title":"Hum Mol Genet"},{"key":"313_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","volume":"20","author":"Consortium HD","year":"2017","unstructured":"Consortium HD. Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice. Nat Neurosci. 2017;20:648\u201360.","journal-title":"Nat Neurosci"},{"key":"313_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet. 2006;15:965\u201377.","journal-title":"Hum Mol Genet"},{"key":"313_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder P, Cantle JP, Chatzopoulou D, Wang N, Gao F, Al-Ramahi I, Lu XH, Ramos EM, El-Zein K, Zhao Y, et al. Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat Neurosci. 2016;19:623\u201333.","journal-title":"Nat Neurosci"},{"key":"313_CR28","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, et al. Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet. 2000;9:1259\u201371.","journal-title":"Hum Mol Genet"},{"key":"313_CR29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/JHD-130072","volume":"2","author":"ZR Crook","year":"2013","unstructured":"Crook ZR, Housman DE. Surveying the landscape of Huntington\u2019s disease mechanisms, measurements, and medicines. J Huntingtons Dis. 2013;2:405\u201336.","journal-title":"J Huntingtons Dis"},{"key":"313_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","volume":"21","author":"A Giralt","year":"2012","unstructured":"Giralt A, Puigdellivol M, Carreton O, Paoletti P, Valero J, Parra-Damas A, Saura CA, Alberch J, Gines S. Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet. 2012;21:1203\u201316.","journal-title":"Hum Mol Genet"},{"key":"313_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","volume":"38","author":"J Labbadia","year":"2013","unstructured":"Labbadia J, Morimoto RI. Huntington\u2019s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci. 2013;38:378\u201385.","journal-title":"Trends Biochem Sci"},{"key":"313_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-1-19","volume":"1","author":"S Li","year":"2006","unstructured":"Li S, Li XJ. Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener. 2006;1:19.","journal-title":"Mol Neurodegener"},{"key":"313_CR33","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1080\/15384101.2015.1033595","volume":"14","author":"T Ratovitski","year":"2015","unstructured":"Ratovitski T, Arbez N, Stewart JC, Chighladze E, Ross CA. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington\u2019s disease (HD). Cell Cycle. 2015;14:1716\u201329.","journal-title":"Cell Cycle"},{"key":"313_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10:83\u201398.","journal-title":"Lancet Neurol"},{"key":"313_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998;95:55\u201366.","journal-title":"Cell"},{"key":"313_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/hmg\/ddp524","volume":"19","author":"IS Seong","year":"2010","unstructured":"Seong IS, Woda JM, Song JJ, Lloret A, Abeyrathne PD, Woo CJ, Gregory G, Lee JM, Wheeler VC, Walz T, et al. Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet. 2010;19:573\u201383.","journal-title":"Hum Mol Genet"},{"key":"313_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","volume":"51","author":"LM Valor","year":"2015","unstructured":"Valor LM. Transcription, epigenetics and ameliorative strategies in Huntington\u2019s Disease: a genome-wide perspective. Mol Neurobiol. 2015;51:406\u201323.","journal-title":"Mol Neurobiol"},{"key":"313_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron. 2005;47:29\u201341.","journal-title":"Neuron"},{"key":"313_CR39","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM. The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA. 2000;97:6763\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR40","doi-asserted-by":"crossref","unstructured":"Marcel V, Nguyen Van Long F, Diaz JJ: 40 Years of Research Put p53 in Translation. Cancers (Basel) 2018, 10.","DOI":"10.3390\/cancers10050152"},{"key":"313_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbabio.2008.10.005","volume":"1787","author":"AV Vaseva","year":"2009","unstructured":"Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta. 2009;1787:414\u201320.","journal-title":"Biochim Biophys Acta"},{"key":"313_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg3682","volume":"15","author":"D Shlyueva","year":"2014","unstructured":"Shlyueva D, Stampfel G, Stark A. Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet. 2014;15:272\u201386.","journal-title":"Nat Rev Genet"},{"key":"313_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nn.4229","volume":"19","author":"MW Vermunt","year":"2016","unstructured":"Vermunt MW, Tan SC, Castelijns B, Geeven G, Reinink P, de Bruijn E, Kondova I, Persengiev S, Netherlands Brain B, Bontrop R, et al. Epigenomic annotation of gene regulatory alterations during evolution of the primate brain. Nat Neurosci. 2016;19:494\u2013503.","journal-title":"Nat Neurosci"},{"key":"313_CR44","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/hmg\/ddv006","volume":"24","author":"M Biagioli","year":"2015","unstructured":"Biagioli M, Ferrari F, Mendenhall EM, Zhang Y, Erdin S, Vijayvargia R, Vallabh SM, Solomos N, Manavalan P, Ragavendran A, et al. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum Mol Genet. 2015;24:2442\u201357.","journal-title":"Hum Mol Genet"},{"key":"313_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","volume":"46","author":"H Jia","year":"2012","unstructured":"Jia H, Pallos J, Jacques V, Lau A, Tang B, Cooper A, Syed A, Purcell J, Chen Y, Sharma S, et al. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington\u2019s disease. Neurobiol Dis. 2012;46:351\u201361.","journal-title":"Neurobiol Dis"},{"key":"313_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","volume":"23","author":"H Jiang","year":"2006","unstructured":"Jiang H, Poirier MA, Liang Y, Pei Z, Weiskittel CE, Smith WW, DeFranco DB, Ross CA. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. Neurobiol Dis. 2006;23:543\u201351.","journal-title":"Neurobiol Dis"},{"key":"313_CR47","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s13311-013-0206-5","volume":"10","author":"J Lee","year":"2013","unstructured":"Lee J, Hwang YJ, Kim KY, Kowall NW, Ryu H. Epigenetic mechanisms of neurodegeneration in Huntington\u2019s disease. Neurotherapeutics. 2013;10:664\u201376.","journal-title":"Neurotherapeutics"},{"key":"313_CR48","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00401-013-1103-z","volume":"125","author":"J Lee","year":"2013","unstructured":"Lee J, Hwang YJ, Shin JY, Lee WC, Wie J, Kim KY, Lee MY, Hwang D, Ratan RR, Pae AN, et al. Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington\u2019s disease. Acta Neuropathol. 2013;125:727\u201339.","journal-title":"Acta Neuropathol"},{"key":"313_CR49","doi-asserted-by":"publisher","first-page":"e41423","DOI":"10.1371\/journal.pone.0041423","volume":"7","author":"KN McFarland","year":"2012","unstructured":"McFarland KN, Das S, Sun TT, Leyfer D, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH. Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington\u2019s disease. PLoS ONE. 2012;7:e41423.","journal-title":"PLoS ONE"},{"key":"313_CR50","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001;291:2423\u20138.","journal-title":"Science"},{"key":"313_CR51","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","volume":"16","author":"G Sadri-Vakili","year":"2007","unstructured":"Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, et al. Histones associated with downregulated genes are hypo-acetylated in Huntington\u2019s disease models. Hum Mol Genet. 2007;16:1293\u2013306.","journal-title":"Hum Mol Genet"},{"key":"313_CR52","doi-asserted-by":"publisher","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas EA, Coppola G, Desplats PA, Tang B, Soragni E, Burnett R, Gao F, Fitzgerald KM, Borok JF, Herman D, et al. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice. Proc Natl Acad Sci USA. 2008;105:15564\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR53","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.2174\/13816128113199990382","volume":"19","author":"LM Valor","year":"2013","unstructured":"Valor LM, Viosca J, Lopez-Atalaya JP, Barco A. Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. Curr Pharm Des. 2013;19:5051\u201364.","journal-title":"Curr Pharm Des"},{"key":"313_CR54","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.1073\/pnas.1415195112","volume":"112","author":"H Jia","year":"2015","unstructured":"Jia H, Morris CD, Williams RM, Loring JF, Thomas EA. HDAC inhibition imparts beneficial transgenerational effects in Huntington\u2019s disease mice via altered DNA and histone methylation. Proc Natl Acad Sci USA. 2015;112:E56\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR55","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/457675a","volume":"457","author":"NJ Allen","year":"2009","unstructured":"Allen NJ, Barres BA. Neuroscience: Glia - more than just brain glue. Nature. 2009;457:675\u20137.","journal-title":"Nature"},{"key":"313_CR56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2009.11.3\/mbelanger","volume":"11","author":"M Belanger","year":"2009","unstructured":"Belanger M, Magistretti PJ. The role of astroglia in neuroprotection. Dialogues Clin Neurosci. 2009;11:281\u201395.","journal-title":"Dialogues Clin Neurosci"},{"key":"313_CR57","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14:724\u201338.","journal-title":"Cell Metab"},{"key":"313_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrn3484","volume":"14","author":"LE Clarke","year":"2013","unstructured":"Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci. 2013;14:311\u201321.","journal-title":"Nat Rev Neurosci"},{"key":"313_CR59","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.neubiorev.2008.02.001","volume":"32","author":"ME Gibbs","year":"2008","unstructured":"Gibbs ME, Hutchinson D, Hertz L. Astrocytic involvement in learning and memory consolidation. Neurosci Biobehav Rev. 2008;32:927\u201344.","journal-title":"Neurosci Biobehav Rev"},{"key":"313_CR60","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1126\/science.1190721","volume":"329","author":"AV Gourine","year":"2010","unstructured":"Gourine AV, Kasymov V, Marina N, Tang F, Figueiredo MF, Lane S, Teschemacher AG, Spyer KM, Deisseroth K, Kasparov S. Astrocytes control breathing through pH-dependent release of ATP. Science. 2010;329:571\u20135.","journal-title":"Science"},{"key":"313_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuron.2008.11.024","volume":"61","author":"MM Halassa","year":"2009","unstructured":"Halassa MM, Florian C, Fellin T, Munoz JR, Lee SY, Abel T, Haydon PG, Frank MG. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron. 2009;61:213\u20139.","journal-title":"Neuron"},{"key":"313_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a020628","volume":"7","author":"H Phatnani","year":"2015","unstructured":"Phatnani H, Maniatis T. Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol. 2015;7:1.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"313_CR63","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn1722","volume":"6","author":"A Volterra","year":"2005","unstructured":"Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci. 2005;6:626\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"313_CR64","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10571-011-9725-y","volume":"31","author":"L Arregui","year":"2011","unstructured":"Arregui L, Benitez JA, Razgado LF, Vergara P, Segovia J. Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington\u2019s disease delays the onset of the motor phenotype. Cell Mol Neurobiol. 2011;31:1229\u201343.","journal-title":"Cell Mol Neurobiol"},{"key":"313_CR65","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci U S A. 2009;106:22480\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"313_CR66","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1523\/JNEUROSCI.0116-08.2008","volume":"28","author":"SY Chou","year":"2008","unstructured":"Chou SY, Weng JY, Lai HL, Liao F, Sun SH, Tu PH, Dickson DW, Chern Y. Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5\/RANTES) by astrocytes. J Neurosci. 2008;28:3277\u201390.","journal-title":"J Neurosci"},{"key":"313_CR67","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects. Hum Mol Genet. 2010;19:3053\u201367.","journal-title":"Hum Mol Genet"},{"key":"313_CR68","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","volume":"22","author":"HY Hsiao","year":"2013","unstructured":"Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y. A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington\u2019s disease. Hum Mol Genet. 2013;22:1826\u201342.","journal-title":"Hum Mol Genet"},{"key":"313_CR69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10863-010-9287-6","volume":"42","author":"JM Oliveira","year":"2010","unstructured":"Oliveira JM. Mitochondrial bioenergetics and dynamics in Huntington\u2019s disease: tripartite synapses and selective striatal degeneration. J Bioenerg Biomembr. 2010;42:227\u201334.","journal-title":"J Bioenerg Biomembr"},{"key":"313_CR70","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol. 2005;171:1001\u201312.","journal-title":"J Cell Biol"},{"key":"313_CR71","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","volume":"23","author":"NH Skotte","year":"2018","unstructured":"Skotte NH, Andersen JV, Santos A, Aldana BI, Willert CW, Norremolle A, Waagepetersen HS, Nielsen ML. Integrative characterization of the R6\/2 mouse model of Huntington\u2019s disease reveals dysfunctional astrocyte metabolism. Cell Rep. 2018;23:2211\u201324.","journal-title":"Cell Rep"},{"key":"313_CR72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD, Anderson MA, Mody I, Olsen ML, Sofroniew MV, Khakh BS. Astrocyte Kir41 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nat Neurosci. 2014;17:694\u2013703.","journal-title":"Nat Neurosci"},{"key":"313_CR73","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O, et al. Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci. 2010;30:10844\u201350.","journal-title":"J Neurosci"},{"key":"313_CR74","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/abbs\/gmr125","volume":"44","author":"L Wang","year":"2012","unstructured":"Wang L, Lin F, Wang J, Wu J, Han R, Zhu L, Zhang G, DiFiglia M, Qin Z. Truncated N-terminal huntingtin fragment with expanded-polyglutamine (htt552-100Q) suppresses brain-derived neurotrophic factor transcription in astrocytes. Acta Biochim Biophys Sin (Shanghai). 2012;44:249\u201358.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"313_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/glia.23050","volume":"65","author":"AH Jansen","year":"2017","unstructured":"Jansen AH, van Hal M, Kelder IC, Meier RT, de Ruiter AA, Schut MH, Smith DL, Grit C, Brouwer N, Kamphuis W, et al. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific. Glia. 2017;65:50\u201361.","journal-title":"Glia"},{"key":"313_CR76","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","volume":"40","author":"BS Khakh","year":"2017","unstructured":"Khakh BS, Beaumont V, Cachope R, Munoz-Sanjuan I, Goldman SA, Grantyn R. Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease. Trends Neurosci. 2017;40:422\u201337.","journal-title":"Trends Neurosci"},{"key":"313_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","volume":"54","author":"JC Hedreen","year":"1995","unstructured":"Hedreen JC, Folstein SE. Early loss of neostriatal striosome neurons in Huntington\u2019s disease. J Neuropathol Exp Neurol. 1995;54:105\u201320.","journal-title":"J Neuropathol Exp Neurol"},{"key":"313_CR78","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-6606-7-46","volume":"7","author":"J Kocerha","year":"2014","unstructured":"Kocerha J, Xu Y, Prucha MS, Zhao D, Chan AW. microRNA-128a dysregulation in transgenic Huntington\u2019s disease monkeys. Mol Brain. 2014;7:46.","journal-title":"Mol Brain"},{"key":"313_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ. Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet. 2001;10:137\u201344.","journal-title":"Hum Mol Genet"},{"key":"313_CR80","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol. 1985;44:559\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"key":"313_CR81","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/jnr.490400414","volume":"40","author":"JA Colombo","year":"1995","unstructured":"Colombo JA, Yanez A, Puissant V, Lipina S. Long, interlaminar astroglial cell processes in the cortex of adult monkeys. J Neurosci Res. 1995;40:551\u20136.","journal-title":"J Neurosci Res"},{"key":"313_CR82","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2004.02.003","volume":"1006","author":"JA Colombo","year":"2004","unstructured":"Colombo JA, Reisin HD. Interlaminar astroglia of the cerebral cortex: a marker of the primate brain. Brain Res. 2004;1006:126\u201331.","journal-title":"Brain Res"},{"key":"313_CR83","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1523\/JNEUROSCI.4707-08.2009","volume":"29","author":"NA Oberheim","year":"2009","unstructured":"Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, Xu Q, Wyatt JD, Pilcher W, Ojemann JG, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29:3276\u201387.","journal-title":"J Neurosci"},{"key":"313_CR84","doi-asserted-by":"publisher","first-page":"e0122335","DOI":"10.1371\/journal.pone.0122335","volume":"10","author":"AW Chan","year":"2015","unstructured":"Chan AW, Jiang J, Chen Y, Li C, Prucha MS, Hu Y, Chi T, Moran S, Rahim T, Li S, et al. Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood. PLoS ONE. 2015;10:e0122335.","journal-title":"PLoS ONE"},{"key":"313_CR85","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2202-15-36","volume":"15","author":"AW Chan","year":"2014","unstructured":"Chan AW, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J, Chi T, Moran S, Engelhardt H, Larkin K, et al. A two years longitudinal study of a transgenic Huntington disease monkey. BMC Neurosci. 2014;15:36.","journal-title":"BMC Neurosci"},{"key":"313_CR86","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/s41598-019-40165-w","volume":"9","author":"SB Lallani","year":"2019","unstructured":"Lallani SB, Villalba RM, Chen Y, Smith Y, Chan AWS. Striatal interneurons in transgenic nonhuman primate model of Huntington\u2019s disease. Sci Rep. 2019;9:3528.","journal-title":"Sci Rep"},{"key":"313_CR87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2016.07.004","volume":"58","author":"J Raper","year":"2016","unstructured":"Raper J, Bosinger S, Johnson Z, Tharp G, Moran SP, Chan AWS. Increased irritability, anxiety, and immune reactivity in transgenic Huntington\u2019s disease monkeys. Brain Behav Immun. 2016;58:181\u201390.","journal-title":"Brain Behav Immun"},{"key":"313_CR88","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"SH Yang","year":"2008","unstructured":"Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, et al. Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature. 2008;453:921\u20134.","journal-title":"Nature"},{"key":"313_CR89","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stemcr.2014.07.011","volume":"3","author":"RL Carter","year":"2014","unstructured":"Carter RL, Chen Y, Kunkanjanawan T, Xu Y, Moran SP, Putkhao K, Yang J, Huang AH, Parnpai R, Chan AW. Reversal of cellular phenotypes in neural cells derived from Huntington\u2019s disease monkey-induced pluripotent stem cells. Stem Cell Reports. 2014;3:585\u201393.","journal-title":"Stem Cell Reports"},{"key":"313_CR90","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/cell.2010.0019","volume":"12","author":"AW Chan","year":"2010","unstructured":"Chan AW, Cheng PH, Neumann A, Yang JJ. Reprogramming Huntington monkey skin cells into pluripotent stem cells. Cell Reprogram. 2010;12:509\u201317.","journal-title":"Cell Reprogram"},{"key":"313_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2121-11-12","volume":"11","author":"C Laowtammathron","year":"2010","unstructured":"Laowtammathron C, Cheng E, Cheng PH, Snyder BR, Yang SH, Johnson Z, Lorthongpanich C, Kuo HC, Parnpai R, Chan AW. Monkey hybrid stem cells develop cellular features of Huntington\u2019s disease. BMC Cell Biol. 2010;11:12.","journal-title":"BMC Cell Biol"},{"key":"313_CR92","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.scr.2013.03.003","volume":"11","author":"A Majumder","year":"2013","unstructured":"Majumder A, Dhara SK, Swetenburg R, Mithani M, Cao K, Medrzycki M, Fan Y, Stice SL. Inhibition of DNA methyltransferases and histone deacetylases induces astrocytic differentiation of neural progenitors. Stem Cell Res. 2013;11:574\u201386.","journal-title":"Stem Cell Res"},{"key":"313_CR93","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7:562\u201378.","journal-title":"Nat Protoc"},{"key":"313_CR94","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, Satpathy AT, Rubin AJ, Montine KS, Wu B, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"313_CR95","first-page":"20","volume":"9","author":"AV Zimin","year":"2014","unstructured":"Zimin AV, Cornish AS, Maudhoo MD, Gibbs RM, Zhang X, Pandey S, Meehan DT, Wipfler K, Bosinger SE. Johnson ZPJBd: A new rhesus macaque assembly and annotation for next-generation sequencing analyses. 2014;9:20.","journal-title":"Johnson ZPJBd: A new rhesus macaque assembly and annotation for next-generation sequencing analyses."},{"key":"313_CR96","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/bioinformatics\/btr189","volume":"27","author":"P Machanick","year":"2011","unstructured":"Machanick P, Bailey TL. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics. 2011;27:1696\u20137.","journal-title":"Bioinformatics"},{"key":"313_CR97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12864-018-4564-6","volume":"19","author":"D Sugiaman-Trapman","year":"2018","unstructured":"Sugiaman-Trapman D, Vitezic M, Jouhilahti EM, Mathelier A, Lauter G, Misra S, Daub CO, Kere J, Swoboda P. Characterization of the human RFX transcription factor family by regulatory and target gene analysis. BMC Genomics. 2018;19:181.","journal-title":"BMC Genomics"},{"key":"313_CR98","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1038\/srep20435","volume":"6","author":"Y Wu","year":"2016","unstructured":"Wu Y, Hu X, Li Z, Wang M, Li S, Wang X, Lin X, Liao S, Zhang Z, Feng X, et al. Transcription Factor RFX2 Is a Key Regulator of Mouse Spermiogenesis. Sci Rep. 2016;6:20435.","journal-title":"Sci Rep"},{"key":"313_CR99","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 30. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"313_CR100","doi-asserted-by":"publisher","first-page":"e64838","DOI":"10.1371\/journal.pone.0064838","volume":"8","author":"M Basu","year":"2013","unstructured":"Basu M, Bhattacharyya NP, Mohanty PK. Comparison of modules of wild type and mutant Huntingtin and TP53 protein interaction networks: implications in biological processes and functions. PLoS ONE. 2013;8:e64838.","journal-title":"PLoS ONE"},{"key":"313_CR101","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.4003","volume":"22","author":"AS Dickey","year":"2016","unstructured":"Dickey AS, Pineda VV, Tsunemi T, Liu PP, Miranda HC, Gilmore-Hall SK, Lomas N, Sampat KR, Buttgereit A, Torres MJ, et al. PPAR-delta is repressed in Huntington\u2019s disease, is required for normal neuronal function and can be targeted therapeutically. Nat Med. 2016;22:37\u201345.","journal-title":"Nat Med"},{"key":"313_CR102","doi-asserted-by":"publisher","first-page":"9925","DOI":"10.1038\/s41598-018-28185-4","volume":"8","author":"I Hervas-Corpion","year":"2018","unstructured":"Hervas-Corpion I, Guiretti D, Alcaraz-Iborra M, Olivares R, Campos-Caro A, Barco A, Valor LM. Early alteration of epigenetic-related transcription in Huntington\u2019s disease mouse models. Sci Rep. 2018;8:9925.","journal-title":"Sci Rep"},{"key":"313_CR103","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12864-017-3745-z","volume":"18","author":"M van Hagen","year":"2017","unstructured":"van Hagen M, Piebes DGE, de Leeuw WC, Vuist IM, van Roon-Mom WMC, Moerland PD, Verschure PJ. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington\u2019s disease cell model. BMC Genomics. 2017;18:373.","journal-title":"BMC Genomics"},{"key":"313_CR104","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR105","doi-asserted-by":"publisher","first-page":"27986","DOI":"10.1074\/jbc.M115.676437","volume":"290","author":"M Lu","year":"2015","unstructured":"Lu M, Boschetti C, Tunnacliffe A. Long term aggresome accumulation leads to DNA damage, p53-dependent cell cycle arrest, and steric interference in mitosis. J Biol Chem. 2015;290:27986\u20138000.","journal-title":"J Biol Chem"},{"key":"313_CR106","first-page":"516","volume":"162","author":"J-M Lee","year":"2015","unstructured":"Lee J-M, Wheeler VC, Chao MJ, Vonsattel JPG, Pinto RM, Lucente D, Abu-Elneel K, Ramos EM, Mysore JS, Gillis TJC. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. 2015;162:516\u201326.","journal-title":"Identification of genetic factors that modify clinical onset of Huntington\u2019s disease."},{"key":"313_CR107","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mcn.2017.12.009","volume":"88","author":"RH Reynolds","year":"2018","unstructured":"Reynolds RH, Petersen MH, Willert CW, Heinrich M, Nymann N, Dall M, Treebak JT, Bjorkqvist M, Silahtaroglu A, Hasholt L, Norremolle A. Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 Huntington\u2019s disease model. Mol Cell Neurosci. 2018;88:118\u201329.","journal-title":"Mol Cell Neurosci"},{"key":"313_CR108","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1128\/MCB.24.9.3747-3756.2004","volume":"24","author":"KL West","year":"2004","unstructured":"West KL, Castellini MA, Duncan MK, Bustin M. Chromosomal proteins HMGN3a and HMGN3b regulate the expression of glycine transporter 1. Mol Cell Biol. 2004;24:3747\u201356.","journal-title":"Mol Cell Biol"},{"key":"313_CR109","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1177\/002215540205000914","volume":"50","author":"Y Ito","year":"2002","unstructured":"Ito Y, Bustin M. Immunohistochemical localization of the nucleosome-binding protein HMGN3 in mouse brain. J Histochem Cytochem. 2002;50:1273\u20135.","journal-title":"J Histochem Cytochem"},{"key":"313_CR110","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME. Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion. Nat Genet. 1997;17:404\u201310.","journal-title":"Nat Genet"},{"key":"313_CR111","first-page":"33","volume":"11","author":"MS Yu","year":"2017","unstructured":"Yu MS, Tanese N. Huntingtin Is Required for Neural But Not Cardiac\/Pancreatic Progenitor Differentiation of Mouse Embryonic Stem Cells In vitro. Front Cell Neurosci. 2017;11:33.","journal-title":"Front Cell Neurosci"},{"key":"313_CR112","doi-asserted-by":"publisher","first-page":"13302","DOI":"10.1073\/pnas.1211289109","volume":"109","author":"G Pontarin","year":"2012","unstructured":"Pontarin G, Ferraro P, Bee L, Reichard P, Bianchi V. Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells. Proc Natl Acad Sci USA. 2012;109:13302\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR113","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"JM Lee","year":"2015","unstructured":"Lee JM, Wheeler VC, Chao MJ, Vonsattel JP, Pinto RM, Lucente D, Abu-Elneel K, Ramos EM, Mysore JS, Gillis T, MacDonald ME. Genetic modifiers of Huntington\u2019s disease C: identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell. 2015;162:516\u201326.","journal-title":"Cell"},{"key":"313_CR114","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, Davidson BL. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol Ther. 2009;17:1053\u201363.","journal-title":"Mol Ther"},{"key":"313_CR115","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ijdevneu.2008.07.016","volume":"26","author":"C Pelegri","year":"2008","unstructured":"Pelegri C, Duran-Vilaregut J, del Valle J, Crespo-Biel N, Ferrer I, Pallas M, Camins A, Vilaplana J. Cell cycle activation in striatal neurons from Huntington\u2019s disease patients and rats treated with 3-nitropropionic acid. Int J Dev Neurosci. 2008;26:665\u201371.","journal-title":"Int J Dev Neurosci"},{"key":"313_CR116","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/glia.20933","volume":"58","author":"VA Swiss","year":"2010","unstructured":"Swiss VA, Casaccia P. Cell-context specific role of the E2F\/Rb pathway in development and disease. Glia. 2010;58:377\u201390.","journal-title":"Glia"},{"key":"313_CR117","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ceb.2007.10.006","volume":"19","author":"PJ Iaquinta","year":"2007","unstructured":"Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol. 2007;19:649\u201357.","journal-title":"Curr Opin Cell Biol"},{"key":"313_CR118","first-page":"731","volume":"6","author":"DG Johnson","year":"2006","unstructured":"Johnson DG, Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med. 2006;6:731\u20138.","journal-title":"Curr Mol Med"},{"key":"313_CR119","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jnc.12655","volume":"129","author":"JH Ting","year":"2014","unstructured":"Ting JH, Marks DR, Schleidt SS, Wu JN, Zyskind JW, Lindl KA, Blendy JA, Pierce RC, Jordan-Sciutto KL. Targeted gene mutation of E2F1 evokes age-dependent synaptic disruption and behavioral deficits. J Neurochem. 2014;129:850\u201363.","journal-title":"J Neurochem"},{"key":"313_CR120","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1038\/onc.2008.117","volume":"27","author":"S Polager","year":"2008","unstructured":"Polager S, Ofir M, Ginsberg D. E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene. 2008;27:4860\u20134.","journal-title":"Oncogene"},{"key":"313_CR121","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/25867","volume":"395","author":"S Bates","year":"1998","unstructured":"Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH. p14ARF links the tumour suppressors RB and p53. Nature. 1998;395:124\u20135.","journal-title":"Nature"},{"key":"313_CR122","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/35078527","volume":"3","author":"MC Moroni","year":"2001","unstructured":"Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Muller H, Helin K. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol. 2001;3:552\u20138.","journal-title":"Nat Cell Biol"},{"key":"313_CR123","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.onc.1202008","volume":"17","author":"PB Dirks","year":"1998","unstructured":"Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells. Oncogene. 1998;17:867\u201376.","journal-title":"Oncogene"},{"key":"313_CR124","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1080\/15384101.2015.1104436","volume":"14","author":"J Wu","year":"2015","unstructured":"Wu J, Sabirzhanov B, Stoica BA, Lipinski MM, Zhao Z, Zhao S, Ward N, Yang D, Faden AI. Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury. Cell Cycle. 2015;14:3698\u2013712.","journal-title":"Cell Cycle"},{"key":"313_CR125","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/jnen\/61.4.358","volume":"61","author":"KL Jordan-Sciutto","year":"2002","unstructured":"Jordan-Sciutto KL, Malaiyandi LM, Bowser R. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol. 2002;61:358\u201367.","journal-title":"J Neuropathol Exp Neurol"},{"key":"313_CR126","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1073\/pnas.0611671104","volume":"104","author":"GU Hoglinger","year":"2007","unstructured":"Hoglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, Alvarez-Fischer D, Boutillier AL, Degregori J, Oertel WH, Rakic P, et al. The pRb\/E2F cell-cycle pathway mediates cell death in Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2007;104:3585\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR127","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/jnen\/62.1.68","volume":"62","author":"KL Jordan-Sciutto","year":"2003","unstructured":"Jordan-Sciutto KL, Dorsey R, Chalovich EM, Hammond RR, Achim CL. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol. 2003;62:68\u201374.","journal-title":"J Neuropathol Exp Neurol"},{"key":"313_CR128","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature06270","volume":"450","author":"K Jepsen","year":"2007","unstructured":"Jepsen K, Solum D, Zhou T, McEvilly RJ, Kim HJ, Glass CK, Hermanson O, Rosenfeld MG. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature. 2007;450:415\u20139.","journal-title":"Nature"},{"key":"313_CR129","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0092-8674(03)00157-0","volume":"112","author":"V Orlando","year":"2003","unstructured":"Orlando V. Polycomb, epigenomes, and control of cell identity. Cell. 2003;112:599\u2013606.","journal-title":"Cell"},{"key":"313_CR130","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.18632\/aging.101005","volume":"8","author":"S Horvath","year":"2016","unstructured":"Horvath S, Langfelder P, Kwak S, Aaronson J, Rosinski J, Vogt TF, Eszes M, Faull RL, Curtis MA, Waldvogel HJ, et al. Huntington\u2019s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels. Aging (Albany NY). 2016;8:1485\u2013512.","journal-title":"Aging (Albany NY)"},{"key":"313_CR131","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1073\/pnas.1221292110","volume":"110","author":"CW Ng","year":"2013","unstructured":"Ng CW, Yildirim F, Yap YS, Dalin S, Matthews BJ, Velez PJ, Labadorf A, Housman DE, Fraenkel E. Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci USA. 2013;110:2354\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR132","doi-asserted-by":"publisher","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ. ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci USA. 2006;103:19176\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"313_CR133","doi-asserted-by":"publisher","first-page":"31022","DOI":"10.1038\/srep31022","volume":"6","author":"Y Pan","year":"2016","unstructured":"Pan Y, Daito T, Sasaki Y, Chung YH, Xing X, Pondugula S, Swamidass SJ, Wang T, Kim AH, Yano H. Inhibition of DNA methyltransferases blocks mutant huntingtin-induced neurotoxicity. Sci Rep. 2016;6:31022.","journal-title":"Sci Rep"},{"key":"313_CR134","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/stem.1787","volume":"32","author":"M Nagao","year":"2014","unstructured":"Nagao M, Lanjakornsiripan D, Itoh Y, Kishi Y, Ogata T, Gotoh Y. High mobility group nucleosome-binding family proteins promote astrocyte differentiation of neural precursor cells. Stem Cells. 2014;32:2983\u201397.","journal-title":"Stem Cells"},{"key":"313_CR135","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1523\/JNEUROSCI.2840-13.2014","volume":"34","author":"L Magri","year":"2014","unstructured":"Magri L, Swiss VA, Jablonska B, Lei L, Pedre X, Walsh M, Zhang W, Gallo V, Canoll P, Casaccia P. E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation. J Neurosci. 2014;34:1481\u201393.","journal-title":"J Neurosci"},{"key":"313_CR136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1210\/me.2002-0107","volume":"17","author":"M Nygard","year":"2003","unstructured":"Nygard M, Wahlstrom GM, Gustafsson MV, Tokumoto YM, Bondesson M. Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol Endocrinol. 2003;17:79\u201392.","journal-title":"Mol Endocrinol"},{"key":"313_CR137","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/2472555216685044","volume":"22","author":"T Kunkanjanawan","year":"2017","unstructured":"Kunkanjanawan T, Carter R, Ahn KS, Yang J, Parnpai R, Chan AWS. Induced pluripotent HD monkey stem cells derived neural cells for drug discovery. SLAS Discov. 2017;22:696\u2013705.","journal-title":"SLAS Discov"},{"key":"313_CR138","doi-asserted-by":"publisher","first-page":"e0162788","DOI":"10.1371\/journal.pone.0162788","volume":"11","author":"T Kunkanjanawan","year":"2016","unstructured":"Kunkanjanawan T, Carter RL, Prucha MS, Yang J, Parnpai R, Chan AW. miR-196a ameliorates cytotoxicity and cellular phenotype in transgenic Huntington\u2019s disease monkey neural cells. PLoS ONE. 2016;11:e0162788.","journal-title":"PLoS ONE"},{"key":"313_CR139","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1745-6150-9-20","volume":"9","author":"AV Zimin","year":"2014","unstructured":"Zimin AV, Cornish AS, Maudhoo MD, Gibbs RM, Zhang X, Pandey S, Meehan DT, Wipfler K, Bosinger SE, Johnson ZP, et al. A new rhesus macaque assembly and annotation for next-generation sequencing analyses. Biol Direct. 2014;9:20.","journal-title":"Biol Direct"},{"key":"313_CR140","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.","journal-title":"Genome Biol"},{"key":"313_CR141","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"313_CR142","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10:1213\u20138.","journal-title":"Nat Methods"},{"key":"313_CR143","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.","journal-title":"Genome Biol"},{"key":"313_CR144","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"313_CR145","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/gb-2012-13-3-r16","volume":"13","author":"Z Shao","year":"2012","unstructured":"Shao Z, Zhang Y, Yuan GC, Orkin SH, Waxman DJ. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets. Genome Biol. 2012;13:R16.","journal-title":"Genome Biol"},{"key":"313_CR146","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"313_CR147","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"313_CR148","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/bioinformatics\/btr064","volume":"27","author":"CE Grant","year":"2011","unstructured":"Grant CE, Bailey TL, Noble WS. FIMO: scanning for occurrences of a given motif. Bioinformatics. 2011;27:1017\u20138.","journal-title":"Bioinformatics"},{"key":"313_CR149","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003;100:9440\u20135.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Epigenetics &amp; Chromatin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-019-0313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13072-019-0313-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-019-0313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T16:50:37Z","timestamp":1722012637000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-019-0313-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1186\/s13072-019-0313-6","relation":{},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"assertion":[{"value":"25 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}